Search Results - "Rubio, Débora"
-
1
VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
Published in Nutrients (01-08-2023)“…Hypovitaminosis D is a public health problem due to its implications for various diseases. Vitamin D has numerous functions, such as modulating the metabolism…”
Get full text
Journal Article -
2
Black skin color but not VDR gene represent a risk factor for low serum levels of vitamin D in self-declared black individuals
Published in Clinical nutrition ESPEN (01-06-2023)“…The absorption of vitamin D occurs via two main pathways: first, through the biosynthesis in the skin under the exposure of UV from sunlight; and second,…”
Get full text
Journal Article -
3
Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae
Published in Antimicrobial agents and chemotherapy (01-11-2017)“…Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore. The spectrum of beta-lactamase inhibition by…”
Get full text
Journal Article -
4
Glomerulonefritis por cambios mínimos post vacuna COVID-19 AstraZeneca
Published in Revista de nefrología, diálisis y transplante (01-01-2022)“…We report a case of a 28-year-old woman with minimal change disease secondary nephrotic syndrome 48 hours after the administration of the AstraZeneca SARS-CoV2…”
Get full text
Journal Article -
5
The Val16Ala MnSOD gene polymorphism is associated with hypertension in self-declared black individuals
Published in Free radical research (01-02-2022)“…Hypertension is the leading contributor to cardiovascular disease worldwide; the prevalence of hypertension is higher among black adults than other…”
Get more information
Journal Article -
6
Evolución de la función renal en pacientes con enfermedad renal crónica con dieta restringida en proteínas suplementada con una mezcla de aminoácidos y cetoanálogos
Published in Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral (01-06-2018)“…Introducción: la enfermedad renal crónica (ERC) es un problema de salud pública. Se ha evaluado el uso de dietas con bajo contenido proteico suplementadas con…”
Get full text
Journal Article -
7
Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae
Published in Antimicrobial agents and chemotherapy (01-12-2017)“…Vaborbactam (formerly RPX7009) is a new β-lactamase inhibitor based on a cyclic boronic acid pharmacophore with potent inhibitory activity against…”
Get full text
Journal Article -
8
In Vitro Activity of the Ultrabroad-Spectrum-Beta-Lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales with Varying Intrinsic and Acquired Resistance Mechanisms
Published in Antimicrobial agents and chemotherapy (22-07-2020)“…QPX7728 is an investigational ultrabroad-spectrum-beta-lactamase inhibitor (BLI) with potent inhibition of key serine and metallo-beta-lactamases. QPX7728…”
Get full text
Journal Article -
9
Intrinsic Antibacterial Activity of Xeruborbactam In Vitro: Assessing Spectrum and Mode of Action
Published in Antimicrobial agents and chemotherapy (18-10-2022)“…Xeruborbactam (formerly QPX7728) is a cyclic boronate inhibitor of numerous serine and metallo-beta-lactamases. At concentrations generally higher than those…”
Get full text
Journal Article -
10
Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases
Published in Antimicrobial agents and chemotherapy (21-05-2020)“…QPX7728 is an ultrabroad-spectrum boronic acid beta-lactamase inhibitor, with potent inhibition of key serine and metallo-beta-lactamases being observed in…”
Get full text
Journal Article -
11
The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Enterobacterales
Published in Antimicrobial agents and chemotherapy (15-02-2022)“…QPX7728 is a cyclic boronate ultrabroad-spectrum beta-lactamase inhibitor, with potent activity against both serine beta-lactamases and…”
Get full text
Journal Article -
12
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Published in Journal of medicinal chemistry (23-07-2020)“…Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among…”
Get full text
Journal Article -
13
Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae , Pseudomonas aeruginosa, and Acinetobacter baumannii
Published in Antimicrobial agents and chemotherapy (21-05-2020)“…QPX7728 is an ultrabroad-spectrum boronic acid beta-lactamase inhibitor that demonstrates inhibition of key serine and metallo-beta-lactamases at a nanomolar…”
Get full text
Journal Article -
14
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
Published in Antimicrobial agents and chemotherapy (01-10-2017)“…Ceftazidime-avibactam is an antibiotic with activity against serine beta-lactamases, including carbapenemase (KPC). Recently, reports have emerged of…”
Get full text
Journal Article -
15
In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa
Published in Antimicrobial agents and chemotherapy (18-05-2021)“…QPX7728 is an ultrabroad-spectrum beta-lactamase inhibitor with potent inhibition of key serine and metallo beta-lactamases. QPX7728 enhances the potency of…”
Get full text
Journal Article -
16
In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
Published in Antimicrobial agents and chemotherapy (20-10-2020)“…QPX7728 is a recently discovered ultra-broad-spectrum beta-lactamase inhibitor (BLI) with potent inhibition of key serine and metallo-beta-lactamases. QPX7728…”
Get full text
Journal Article -
17
In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales
Published in Antimicrobial agents and chemotherapy (15-11-2023)“…Recently, several β-lactam (BL)/β-lactamase inhibitor (BLI) combinations have entered clinical testing or have been marketed for use, but limited direct…”
Get full text
Journal Article -
18
Potency of Meropenem-Vaborbactam in Lung Surfactant
Published in Antimicrobial agents and chemotherapy (01-01-2018)“…This study investigated whether pulmonary surfactant has an effect on the antibacterial activity of either meropenem alone or meropenem in combination with…”
Get full text
Journal Article -
19
Development and Implementation of a Verification Protocol for Regulatory Compliance of Electrical Systems in Critical Hospital Areas
Published in 2024 IEEE Biennial Congress of Argentina (ARGENCON) (18-09-2024)“…Electrical safety in critical hospital areas is paramount for protecting patients, medical personnel, and biomedical equipment. This work presents a…”
Get full text
Conference Proceeding -
20
Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae
Published in Antimicrobial agents and chemotherapy (01-01-2018)“…Meropenem-vaborbactam (Vabomere) is highly active against Gram-negative pathogens, especially carbapenemase (KPC)-producing, carbapenem-resistant The objective…”
Get full text
Journal Article